AIFU (AIFU) Competitors $8.17 -1.03 (-11.20%) As of 07/25/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock AIFU vs. NEUE, HIT, AAME, ZBAO, HUIZ, FGF, OXBR, CNFR, TIRX, and XHGShould you be buying AIFU stock or one of its competitors? The main competitors of AIFU include NeueHealth (NEUE), Health In Tech (HIT), Atlantic American (AAME), Zhibao Technology (ZBAO), Huize (HUIZ), Fundamental Global (FGF), Oxbridge Re (OXBR), Conifer (CNFR), Tian Ruixiang (TIRX), and XChange TEC.INC. (XHG). These companies are all part of the "insurance" industry. AIFU vs. Its Competitors NeueHealth Health In Tech Atlantic American Zhibao Technology Huize Fundamental Global Oxbridge Re Conifer Tian Ruixiang XChange TEC.INC. AIFU (NASDAQ:AIFU) and NeueHealth (NYSE:NEUE) are both small-cap insurance companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, profitability, valuation, earnings, risk and dividends. Which has more risk and volatility, AIFU or NEUE? AIFU has a beta of 0.53, meaning that its share price is 47% less volatile than the S&P 500. Comparatively, NeueHealth has a beta of 0.57, meaning that its share price is 43% less volatile than the S&P 500. Does the media prefer AIFU or NEUE? In the previous week, AIFU and AIFU both had 1 articles in the media. AIFU's average media sentiment score of 1.87 beat NeueHealth's score of 0.00 indicating that AIFU is being referred to more favorably in the media. Company Overall Sentiment AIFU Very Positive NeueHealth Neutral Do insiders & institutionals hold more shares of AIFU or NEUE? 26.7% of AIFU shares are held by institutional investors. Comparatively, 63.9% of NeueHealth shares are held by institutional investors. 25.6% of AIFU shares are held by insiders. Comparatively, 63.3% of NeueHealth shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Do analysts rate AIFU or NEUE? NeueHealth has a consensus price target of $7.00, suggesting a potential upside of 3.09%. Given NeueHealth's stronger consensus rating and higher possible upside, analysts clearly believe NeueHealth is more favorable than AIFU.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AIFU 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00NeueHealth 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has preferable earnings & valuation, AIFU or NEUE? AIFU has higher earnings, but lower revenue than NeueHealth. NeueHealth is trading at a lower price-to-earnings ratio than AIFU, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAIFU$247.81M0.10$62.33M$0.7311.19NeueHealth$936.66M0.06-$134.68M-$22.00-0.31 Is AIFU or NEUE more profitable? AIFU has a net margin of 0.00% compared to NeueHealth's net margin of -14.28%. Company Net Margins Return on Equity Return on Assets AIFUN/A N/A N/A NeueHealth -14.28%N/A -17.46% SummaryAIFU beats NeueHealth on 7 of the 13 factors compared between the two stocks. Get AIFU News Delivered to You Automatically Sign up to receive the latest news and ratings for AIFU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AIFU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AIFU vs. The Competition Export to ExcelMetricAIFUINS IndustryFinance SectorNASDAQ ExchangeMarket Cap$26.64M$20.56B$12.28B$9.50BDividend YieldN/A2.93%5.54%4.01%P/E Ratio11.1913.1019.0320.05Price / Sales0.102.0626.1090.07Price / Cash0.5616.8421.6358.56Price / Book0.062.022.205.87Net Income$62.33M$1.60B$997.25M$258.55M7 Day Performance15.07%0.92%0.60%3.74%1 Month Performance67.42%1.01%3.44%11.75%1 Year PerformanceN/A12.83%536.57%18.03% AIFU Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AIFUAIFUN/A$8.17-11.2%N/AN/A$26.64M$247.81M11.194,707Positive NewsNEUENeueHealth0.7921 of 5 stars$6.88+0.9%$7.00+1.7%+13.0%$60.89M$936.66M-0.311,252News CoverageHITHealth In TechN/A$1.09+3.8%$2.50+129.4%N/A$59.59M$22.38M0.0079News CoverageEarnings ReportAnalyst UpgradeGap UpAAMEAtlantic American0.9172 of 5 stars$1.95-2.5%N/A+38.8%$40.79M$191.36M-21.66140ZBAOZhibao TechnologyN/A$1.01flatN/A-73.6%$31.84M$25.27M0.00148HUIZHuize0.8969 of 5 stars$2.69-2.2%$2.30-14.5%-89.2%$27.74M$171.10M-6.401,640Positive NewsGap DownFGFFundamental Global2.8437 of 5 stars$17.18-1.3%N/A-19.7%$22.14M$17.35M13.119Positive NewsGap UpOXBROxbridge Re2.1291 of 5 stars$2.21-9.8%$5.00+126.2%-40.4%$16.45M$1.36M-7.373CNFRConifer2.4571 of 5 stars$0.81+2.5%N/A+3.0%$9.66M$67.27M0.41150Positive NewsTIRXTian Ruixiang1.8265 of 5 stars$1.16-3.8%N/A-51.4%$870K$3.22M0.0050XHGXChange TEC.INC.N/A$1.43+5.9%N/AN/A$20K$41.09M0.0030Positive News Related Companies and Tools Related Companies NeueHealth Alternatives Health In Tech Alternatives Atlantic American Alternatives Zhibao Technology Alternatives Huize Alternatives Fundamental Global Alternatives Oxbridge Re Alternatives Conifer Alternatives Tian Ruixiang Alternatives XChange TEC.INC. Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AIFU) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIFU Inc. - Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share AIFU With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.